FMT plus systemic therapy in renal cell cancer
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP600444
下载链接
链接失效反馈官方服务：
资源简介：
The PERFORM trial is a prospective clinical study evaluating the impact of fecal microbiota transplantation (FMT) in combination with immune checkpoint inhibitor-based therapy in patients with metastatic renal cell carcinoma. The trial aims to determine whether FMT can enhance treatment efficacy and reduce toxicity by modulating the gut microbiome.
创建时间：
2025-07-15
